1
|
Koistinaho J, Hervonen A. Neuronal degeneration and lipopigment formation in rat sympathetic ganglion after treatment with high-dose guanethidine. Neurosci Lett 1989; 102:349-54. [PMID: 2812512 DOI: 10.1016/0304-3940(89)90104-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Degenerative changes in the rat superior cervical ganglion (SCG) were studied 3 months after treatment with a high-dose of guanethidine using microspectrofluorometry and electron microscopy. The density of the SCG neurons was decreased by 30% and by 60% following 1 and 2 weeks treatment respectively with guanethidine. Intraneuronal lipopigments were increased after the treatment, whereas cytoplasmic catecholamines were decreased. Electron microscopy revealed swollen mitochondria and a novel type of lipo-pigment in surviving neurons. The number and structure of small intensely fluorescent (SIF) cells remained unchanged after the treatment. The results suggest that accelerated lipid peroxidation processes might be involved in guanethidine neurotoxicity and that intraneuronal concentrations of catecholamines may be related to this toxicity.
Collapse
Affiliation(s)
- J Koistinaho
- Department of Public Health, University of Tampere, Finland
| | | |
Collapse
|
2
|
Kidd GJ, Heath JW, Dunkley PR. Degeneration of myelinated sympathetic nerve fibres following treatment with guanethidine. JOURNAL OF NEUROCYTOLOGY 1986; 15:561-72. [PMID: 3772403 DOI: 10.1007/bf01611857] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The specificity and characteristics of the degeneration of myelinated axons after chronic guanethidine treatment have been investigated in sympathetic and non-sympathetic nerves. Adult male Sprague-Dawley rats aged approximately 43 weeks were treated with guanethidine sulphate (50 mg per kg body weight per day) for between ten days and six weeks. Tissues were examined by qualitative and quantitative light and electron microscopy. In the superior cervical (sympathetic) ganglion (SCG), guanethidine treatment produced a 78% decrease (P = 0.009) in the mean number of myelinated fibres at a standard level of section, compared to the contralateral control ganglion which was removed surgically prior to drug treatment. This reduction in the treated SCG was apparent after 10 days, though complete degeneration of nerve cell bodies was not widespread at this stage. Degeneration of unmyelinated axons was extensive. Degenerating myelinated fibres were consistently small in diameter (up to approximately 3 microns). In individual myelinated fibres the earliest signs of degeneration involved disruption of axonal organelles, particularly the cytoskeleton, and focal widening of the periaxonal space. Myelin breakdown followed these events; degeneration of myelin still associated with a structurally intact axon was not observed. Myelin breakdown appeared to take place initially within the Schwann cell, at least to the stage of 'loosened' membranes. However, infiltrating cells were also involved in myelin phagocytosis. At all stages of treatment some small diameter myelinated fibres remained intact, and there was no evidence of degeneration of the larger diameter fibres (up to approximately 15 microns) which are consistently present in small numbers in the SCG. In the cervical sympathetic trunk, which carries preganglionic axons to the SCG and the vagus and sciatic nerves, degeneration only of unmyelinated axons was detected. These results indicate that guanethidine does not exert a primary degenerative influence on myelin or myelinating Schwann cells and that the myelin degeneration observed in the SCG is a secondary result of the previously documented selectively destructive effect of guanethidine on postganglionic sympathetic neurons. Surviving, small diameter myelinated fibres in the SCG could be either preganglionic or processes of resistant postganglionic neurons, while the larger diameter fibres are likely to be somatic. While the cervical sympathetic trunk, vagus and sciatic nerves all contain postganglionic sympathetic fibres it appears that few of these are myelinated, at least at the levels sampled in this study.
Collapse
|
3
|
Johnson EM, Palmatier MA, Rydel RE, Manning PT. Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline). Brain Res 1986; 383:100-9. [PMID: 3768685 DOI: 10.1016/0006-8993(86)90011-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Guanacline, a guanidinium adrenergic neuron blocking agent similar to guanethidine, was studied clinically and experimentally during the late 1960s. Like guanethidine, it has been reported to produce sympathetic neuronal destruction in rats. Unlike guanethidine, it has been reported to produce irreversible sympathetic deficits in man and to produce fluorescent lipopigment in rat sympathetic neurons. Guanacline and its derivative in which the double bond of the tetrahydropyridine ring is reduced (saturated analog of guanacline, SAG) were prepared. Several species were treated chronically with varying doses of guanethidine, guanacline or SAG; the superior cervical ganglia were examined light microscopically for neuronal destruction and for osmiophilic fluorescent lipopigment accumulation. All 3 drugs produced rapid neuronal destruction in rats accompanied by massive small-cell infiltration. In striking contrast, treatment for many weeks with doses up to 100 mg/kg/day produced no small-cell infiltration or apparent neuronal destruction in mice or guinea pigs. The neuronal destruction produced by guanacline and SAG in the rat, like that caused by guanethidine, was prevented by immunosuppression or gamma-irradiation, indicating that all 3 agents produce neuronal destruction in rats by an immune-mediated mechanism. Thus, the ability of the drug to produce sympathectomy is species specific but not drug specific. The opposite was found with respect to fluorescent lipopigment accumulation. Guanacline, but not guanethidine or SAG, produced fluorescent lipopigment in all species examined. Therefore, the double bond of the tetrahydropyridine ring plays a critical role in the production of the fluorescent lipopigment.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
|
4
|
Ekström J. The effect of reserpine treatment on choline acetyltransferase activity in rat submaxillary glands. ACTA PHYSIOLOGICA SCANDINAVICA 1986; 126:103-6. [PMID: 3953297 DOI: 10.1111/j.1748-1716.1986.tb07792.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Rats were treated daily with a low dose of reserpine (0.1 mg kg-1) injected subcutaneously for 3 weeks. In the submaxillary glands the noradrenaline content was reduced by about 95%. The total activity of the acetylcholine-synthesizing enzyme choline acetyltransferase remained unchanged. However, the activity of this enzyme was found to be increased when the reserpine treatment was followed by surgical sympathetic denervation and the glands were analysed 3 weeks post-operatively. The enzyme activity also increased in the glands when the surgical sympathetic denervation was performed on the day of the start of the reserpine treatment. The lack of effect of reserpine on choline acetyltransferase activity in the glands seems to exclude the possibility that it is the depletion of neuronal noradrenaline stores that initiates the events giving rise to increases in choline acetyltransferase activity after sympathetic denervation.
Collapse
|
5
|
Johnson EM, Manning PT. Guanethidine-induced destruction of sympathetic neurons. INTERNATIONAL REVIEW OF NEUROBIOLOGY 1984; 25:1-37. [PMID: 6206012 DOI: 10.1016/s0074-7742(08)60676-5] [Citation(s) in RCA: 83] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
6
|
Terris JM. Effect of chronic guanethidine treatment on vascular norepinephrine content in the neonatal domestic pig. Life Sci 1983; 33:719-23. [PMID: 6888189 DOI: 10.1016/0024-3205(83)90776-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Vinblastine, 6-hydroxydopamine, and antibody to nerve growth factor have been shown to destroy sympathetic neurons in neonatal rats. High doses of guanethidine produce permanent sympathectomies in the adult or newborn rat. Similar studies in the cat, rabbit, and hamster demonstrate that the sympathetic nervous systems are not destroyed with guanethidine. To produce permanent sympathectomy in a large animal model, guanethidine was administered to neonatal pigs. As with the cat, rabbit, and hamster, the sympathetic nervous system in the piglets was not destroyed by guanethidine.
Collapse
|
7
|
Beckman cleavage of 1,2,3,4,5,6-hexahydro-3,6-dimethyl-2,6-methano-3-benzazocin-11-one oxime (2,5-dimethyl-9-oxo-6,7-benzomorphan oxime); a new route to 3-benzazocines. Tetrahedron Lett 1983. [DOI: 10.1016/s0040-4039(00)81423-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
8
|
Johnson EM, Hunter FE. Chemical sympathectomy by guanidinium adrenergic neuron blocking agents. Biochem Pharmacol 1979; 28:1525-31. [PMID: 475863 DOI: 10.1016/0006-2952(79)90468-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
9
|
Grobecker H, Roizen MF, Jacobowitz DM, Kopin IJ. Effect of prolonged treatment with adrenergic neuron blocking drugs on sympathoadrenal reactivity in rats. Eur J Pharmacol 1977; 46:125-33. [PMID: 590325 DOI: 10.1016/0014-2999(77)90248-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
The effects of repeated high doses of the adrenergic neuron blocking drug guanethidine or a hexahydropyrazinoindole compound (2-guanyl-1,2,3,10,10a, hexahydro-1,2,a-pyrazinoindole, EMD 21192) (30 mg/kg i.p., 21.5 mg/kg i.p. respectively, equimolar doses) on sympathoadrenal activity were investigated in normotensive adult rats. During treatment for 5 weeks with either guanethidine or EMD 21192 the systemic blood pressure fell steadily. Noradrenaline content in the heart and vas deferens were decreased markedly by guanethidine and to a much less degree by EMD 21192. EMD 21192 markedly lowers the catecholamine content of the adrenal medulla, presumably as a result of inhibition of dopamine-beta-hydroxylase. The plasma catecholamine concentrations reflected the different sites of action of the drugs in the sympathoadrenal system, i.e. guanethidine mainly reduced circulating norepinephrine and dopamine-beta-hydroxylase by more than 50%, whereas EMD 21192 decreased considerably by the total catecholamines (mainly epinephrine) without altering significantly in the plasma norepinephrine. Disappearance or reduction of fluorescent nerve endings in the iris and the heart and a decrease of the intensity of fluorescence in chromaffin cells of the adrenal gland caused by the drugs were consistent with the biochemical alteration. Whereas the repeated doses of guanethidine caused degeneration of sympathetic nerves, destruction of adrenergic neurons was not found after prolonged treatment with EMD 21192.
Collapse
|
10
|
Heath JW, Burnstock G. Selectivity of neuronal degeneration produced by chronic guanethidine treatment. JOURNAL OF NEUROCYTOLOGY 1977; 6:397-405. [PMID: 894332 DOI: 10.1007/bf01178225] [Citation(s) in RCA: 38] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Chronic guanethidine treatment of rats produced extensive damage to sympathetic neurons of the superior cervical ganglion and pelvic plexus. No ultrastuctural changes were observed in parasympathetic cholinergic neurons in the ciliary ganglion and pelvic plexus, nor in sensory neurons in nodose and dorsal root ganglia. A total of only six nerve cell bodies free of degenerative changes were observed in sections of superior cervical ganglia from 20 rats. This suggests either that the earlier estimates of 5% cholinergic neurons in the superior cervical ganglion based on acetylcholinesterase staining are too high, or implies that sympathetic cholinergic neurons, unlike parasympathetic neurons, are damaged by chronic guanethidine treatment.
Collapse
|
11
|
Lorez HP. Catecholamine fluorescence in the brains of chemically sympathectomized adult rats: increased fluorescence in bulbospinal neurons. Brain Res 1977; 128:361-8. [PMID: 326351 DOI: 10.1016/0006-8993(77)91002-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
12
|
Murdoch SD, Evans BK, Heath JW, Hill CE, Burnstock G. Effects of chronic bretylium treatment on the sympathetic neuron and the smooth musculature of the rat. Eur J Pharmacol 1977; 43:225-35. [PMID: 872877 DOI: 10.1016/0014-2999(77)90021-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The effects of chronic i.p. injection of high doses of bretylium on sympathetic nerves on the smooth musculature of the vas deferens of adult and newborn rats were examined using fluorescence histochemistry, light and electron microscopy and organ bath physiological techniques. Bretylium treatment caused mitochondrial swelling, loss of cristae and the formation of electron-dense inclusions in the mitochondria of sympathetic neurons. However, neuron degeneration was not observed and fluorescent histochemical appearance of adrenergic neurons was normal. A small transient supersensitivity of the isolated vas deferens of bretylium-treated rats to noradrenaline, but not to acetylcholine, occurred. There was, however, considerable increase in the maximal contractile response to both noradrenaline and acetylcholine. In high calcium concentrations acetylcholine-induced contractions of vasa deferentia from bretylium-treated rats were significantly greater than control; there was no difference in magnitude of noradrenaline-induced contractions.
Collapse
|
13
|
Eccher S, Dodson C, Quissell DO, Martinez JR. Submaxillary secretion in rats treated with guanethidine. Eur J Pharmacol 1977; 41:113-21. [PMID: 832670 DOI: 10.1016/0014-2999(77)90200-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The composition of final submaxillary saliva and of whole gland homogenates were compared in rats treated with 14 daily doses of guanethidine (20 mg/kg body weight) and in untreated controls after stimulation with pilocarpine (10 mg/kg) or carbamylcholine (50-100 mg/kg). A 44% reduction in the volume of saliva and elevations in the salivary concentrations of K+, Ca2+ and protein were found in the treated animals after pilocarpine stimulation. Similarly, a 25% reduction in salivary volume and elevations in salivary Ca2+ and protein concentrations were observed following stimulation with carbamylcholine. A less significant elevation in salivary K+ was seen after this secretagogue. The Na+ and protein contents, but not the K+ and Ca2+ contents, were found to be elevated in the glands of the treated animals in the resting (unstimulated) state. After stimulation with the two secretagogues, however, similar changes in glandular Na+ and K+ contents were found in the glands of control and treated animals. The glandular water content was also similar in both types of glands in the resting and stimulated states. It is concluded that a reduced salivary secretion, rather than supersensitivity, is observed in the rat submaxillary gland following chronic guanethidine administration. The drug treatment does not impair the glandular electrolyte changes that occur upon stimulation, but most likely impairs the release of protein from the gland and also transductal K+ transport. Both these effects may result from the depletion of sympathetic neurotransmitter caused by the guanethidine administration.
Collapse
|
14
|
Chang PL, Taylor JJ, Wozniak W, Young PA. An ultrastructural study of sympathetic ganglion satellite cells in the rat. 2. Effect of preganglionic sympathectomy. J Neural Transm (Vienna) 1976; 38:43-57. [PMID: 1262863 DOI: 10.1007/bf01254139] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The ultrastructure of satellite cells of the rat superior cervical ganglion was studied following preganglionic sympathectomy.Several distinct morphological alterations were observed: (a) enlargement of the intercellular space between the ganglion cells and the satellite cells, (b) dilation of the granular endoplasmic reticulum and loss of attached ribosomes, and (c) swelling of the mitochondria with disorganization of the cristae mitochondriales. The presence of degenerating nerve fibers and synaptic boutons was also noted.
Collapse
|
15
|
Lorez HP, Kettler R. Absence of degeneration of adrenergic neurones after prolonged treatment of newborn rats with debrisoquin. ACTA PHARMACOLOGICA ET TOXICOLOGICA 1975; 36:132-44. [PMID: 237399 DOI: 10.1111/j.1600-0773.1975.tb00779.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
16
|
Johnson EM, Aloe L. Suppression of the in vitro and in vivo cytotoxic effects of guanethidine in sympathetic neurons by nerve growth factor. Brain Res 1974; 81:519-32. [PMID: 4140011 DOI: 10.1016/0006-8993(74)90848-8] [Citation(s) in RCA: 32] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|